These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31150821)

  • 1. Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT.
    Li Y; Hong J; Jung BK; Oh E; Yun CO
    Cancer Lett; 2019 Sep; 459():15-29. PubMed ID: 31150821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer.
    Li Y; Hong J; Oh JE; Yoon AR; Yun CO
    Int J Cancer; 2018 Jan; 142(2):392-413. PubMed ID: 28929492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer.
    Jung KH; Choi IK; Lee HS; Yan HH; Son MK; Ahn HM; Hong J; Yun CO; Hong SS
    Cancer Lett; 2017 Jun; 396():155-166. PubMed ID: 28315430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer.
    Lee JS; Hur MW; Lee SK; Choi WI; Kwon YG; Yun CO
    PLoS One; 2012; 7(5):e36520. PubMed ID: 22606268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.
    Zhao H; Wang H; Kong F; Xu W; Wang T; Xiao F; Wang L; Huang D; Seth P; Yang Y; Wang H
    Hum Gene Ther; 2019 Feb; 30(2):197-210. PubMed ID: 30032645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.
    Choi IK; Lee YS; Yoo JY; Yoon AR; Kim H; Kim DS; Seidler DG; Kim JH; Yun CO
    Gene Ther; 2010 Feb; 17(2):190-201. PubMed ID: 19907500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
    Oh E; Choi IK; Hong J; Yun CO
    Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases.
    Yang Y; Xu W; Neill T; Hu Z; Wang CH; Xiao X; Stock SR; Guise T; Yun CO; Brendler CB; Iozzo RV; Seth P
    Hum Gene Ther; 2015 Dec; 26(12):813-25. PubMed ID: 26467629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
    Xu W; Neill T; Yang Y; Hu Z; Cleveland E; Wu Y; Hutten R; Xiao X; Stock SR; Shevrin D; Kaul K; Brendler C; Iozzo RV; Seth P
    Gene Ther; 2015 Mar; 22(3):247-56. PubMed ID: 25503693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role mediated by adenoviral E1A in suppressing cancer through modulating decorin.
    Ge Y; Zhang W; Qin J; Zhang C; Tian W; Zhang Q; Shao J; Li S; Fang L; Zheng J
    Med Oncol; 2019 Oct; 36(12):96. PubMed ID: 31659495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration.
    Na Y; Nam JP; Hong J; Oh E; Shin HC; Kim HS; Kim SW; Yun CO
    J Control Release; 2019 Jul; 305():75-88. PubMed ID: 31071373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.
    Bhattacharyya M; Francis J; Eddouadi A; Lemoine NR; Halldén G
    Cancer Gene Ther; 2011 Oct; 18(10):734-43. PubMed ID: 21836633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus.
    Kaliberov SA; Kaliberova LN; Buchsbaum DJ; Curiel DT
    Cancer Gene Ther; 2014 Jul; 21(7):264-74. PubMed ID: 24903014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.
    Chu QD; Sun G; Pope M; Luraguiz N; Curiel DT; Kim R; Li BD; Mathis JM
    Surgery; 2012 Sep; 152(3):441-8. PubMed ID: 22853858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.
    Bots STF; Harryvan TJ; Groeneveldt C; Kinderman P; Kemp V; van Montfoort N; Hoeben RC
    Mol Oncol; 2024 May; 18(5):1245-1258. PubMed ID: 38037840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
    Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
    Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells.
    Bofill-De Ros X; Villanueva E; Fillat C
    Oncotarget; 2015 Mar; 6(8):6179-90. PubMed ID: 25714032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.